RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy

References

Page 1

	Year	Citations
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Ting‐Chao Chou, Paul Talalay Advances in Enzyme Regulation Pharmacological StudyPharmacoepidemiologyQuantitative AnalysisPharmacologyDose-effect Relationships	1984	7.1K
Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network	2017	1.3K
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals Yiguang Wang, Ke‐Jin Zhou, Gang Huang, Nature Materials NanomedicineTissue ImagingEngineeringBroad RangeNonlinear Amplification	2013	763
PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties Konstantinos Avgoustakis Journal of Controlled Release NanomedicineEngineeringTherapeutic NanomaterialsMedicinePharmaceutical Nanotechnology	2002	497
A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands Xiaohua Huang, Xianghong Peng, Yiqing Wang, ACS Nano	2010	424
Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery Jinjun Shi, Zeyu Xiao, Alexander R. Votruba, Angewandte Chemie International Edition NanoparticlesFluorescence MicroscopyNanomedicineLipid PreparationNanotherapeutics	2011	193
Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer Fengqiao Li, Hao Mei, Yu Gao, Biomaterials Hypoxia-induced Drug ResistanceAptamer-modified Liposomal ComplexesPolymer-drug ConjugateMedicineTumor Targeting	2017	152
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment Liqiong Cai, Gaofei Xu, Changying Shi, Biomaterials NanomedicineOncologyNanotherapeuticsSynergistic Combination NanotherapyTelodendrimer Nanocarrier	2014	147
Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer Bo Liu, Han Li, Junyan Liu, International Journal of Nanomedicine	2017	121
Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity<i>in vitro</i>and<i>in vivo</i> Jieke Yan, Yuzhen Wang, Xufeng Zhang, Drug Delivery	2015	117

Page 1